Log in to save to my catalogue

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lym...

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lym...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4648526

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

About this item

Full title

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2015-09, Vol.5 (9), p.e350-e350

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Alternative Titles

Full title

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4648526

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4648526

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/bcj.2015.80

How to access this item